Protagonist Therapeutics, Inc. (PTGX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 613.46M | 577.57M | 586.42M | 602.53M | 605.86M | 591.64M | 476.77M | 570.92M | 627.55M | 355.58M | 324.88M | 316.94M |
| Cash & Short-Term Investments | 547.79M | 567.36M | 576.12M | 570.47M | 574.36M | 418.91M | 468.72M | 564M | 322.63M | 341.62M | 320.75M | 313.4M |
| Cash Only | 193.71M | 128.39M | 113.71M | 168.54M | 139.65M | 97.25M | 131.12M | 355.64M | 172.57M | 186.73M | 230.53M | 235.38M |
| Short-Term Investments | 354.07M | 438.97M | 462.4M | 401.92M | 434.71M | 321.66M | 337.6M | 208.35M | 150.07M | 154.89M | 90.22M | 78.02M |
| Accounts Receivable | 0 | 4.5M | 583K | 27.97M | 27.09M | 168.49M | 2.67M | 1.37M | 300.4M | 10.33M | 65K | 50K |
| Days Sales Outstanding | - | 31.42 | 278.75 | 451.71 | 310.76 | 46.14 | 39.74 | 3.3K | 55.46 | 7.97 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 65.67M | 0 | 4.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 84M | 92.32M | 115.26M | 115.48M | 136.27M | 153.08M | 127.09M | 43.7M | 1.72M | 2.37M | 5.13M | 3.52M |
| Property, Plant & Equipment | 11.17M | 11.69M | 12.27M | 12.7M | 12.53M | 12.61M | 12.3M | 12.03M | 1.5M | 2.15M | 2.92M | 3.3M |
| Fixed Asset Turnover | - | 0.62x | 0.38x | 0.44x | 2.25x | 13.70x | 0.38x | 0.62x | 139.82x | 23.65x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 78.92M | 102.7M | 102.49M | 123.52M | 140.25M | 114.56M | 31.45M | 0 | 0 | 1.99M | 0 |
| Other Non-Current Assets | 72.84M | 0 | 287K | 290K | 225K | 225K | 225K | 225K | 225K | 225K | 225K | 225K |
| Total Assets | 697.46M | 669.89M | 701.69M | 718.01M | 742.13M | 744.73M | 603.86M | 614.63M | 629.28M | 357.95M | 330.02M | 320.47M |
| Asset Turnover | - | 0.01x | 0.01x | 0.01x | 0.04x | 0.25x | 0.01x | 0.01x | 0.52x | 0.17x | - | - |
| Asset Growth % | -6.02% | -10.05% | 16.2% | 16.82% | 17.93% | 108.05% | 82.98% | 91.79% | 162.35% | 44.38% | 16.95% | 3.21% |
| Total Current Liabilities | 34.55M | 45.44M | 44.94M | 35.51M | 35.11M | 47.4M | 44.58M | 41.58M | 39.91M | 21.27M | 27.87M | 26.4M |
| Accounts Payable | 8.44M | 5.34M | 5.65M | 3.25M | 2.92M | 1.61M | 3.05M | 3.63M | 3.51M | 772K | 1.25M | 4.57M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 2.34M | 2.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 6.28M | 9.55M | 0 | 14.69M | 16.89M | 18.89M | 19.7M | 20.12M | 16.13M | 0 | 3K | 10K |
| Other Current Liabilities | 17.49M | 15.51M | 14.39M | 5.01M | 2.9M | 23.69M | 20.62M | 5.45M | 2.46M | 6.79M | 4.53M | 3.63M |
| Current Ratio | 17.76x | 12.71x | 13.05x | 16.97x | 17.26x | 12.48x | 10.70x | 13.73x | 15.72x | 16.71x | 11.66x | 12.01x |
| Quick Ratio | 17.76x | 12.71x | 13.05x | 16.97x | 17.26x | 12.48x | 10.70x | 13.73x | 15.72x | 16.71x | 11.66x | 12.01x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.44M | 9.74M | 11.31M | 14.48M | 17.97M | 22.03M | 27.36M | 31.73M | 28.92M | 0 | 0 | 0 |
| Long-Term Debt | 7.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 8.04M | 8.52M | 9.11M | 9.79M | 10.36M | 10.86M | 10.97M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 1.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 221K | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 2.79M | 5.38M | 8.18M | 11.68M | 16.51M | 0 | 0 | -221K | 0 | 0 |
| Total Liabilities | 41.99M | 55.19M | 56.25M | 49.99M | 53.08M | 69.43M | 71.94M | 73.31M | 68.83M | 21.27M | 27.87M | 26.4M |
| Total Debt | 9.78M | 10.32M | 10.75M | 11.28M | 11.36M | 10.87M | 10.9M | 10.97M | 462K | 1.14M | 1.8M | 2.45M |
| Net Debt | -183.94M | -118.07M | -102.96M | -157.26M | -128.29M | -86.38M | -120.22M | -344.67M | -172.11M | -185.59M | -228.72M | -232.94M |
| Debt / Equity | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.00x | 0.00x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | 0.09x | - | - | 0.00x | 0.05x | - | - |
| Net Debt / EBITDA | - | - | - | - | - | -0.68x | - | - | -0.83x | -7.77x | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 655.47M | 614.71M | 645.44M | 668.02M | 689.05M | 675.29M | 531.91M | 541.32M | 560.44M | 336.68M | 302.15M | 294.07M |
| Equity Growth % | -4.87% | -8.97% | 21.34% | 23.4% | 22.95% | 100.58% | 76.04% | 84.08% | 159.26% | 56.15% | 24.03% | 9.74% |
| Book Value per Share | 9.30 | 9.67 | 10.12 | 10.52 | 10.94 | 10.17 | 8.61 | 8.83 | 8.81 | 5.45 | 5.11 | 5.18 |
| Total Shareholders' Equity | 655.47M | 614.71M | 645.44M | 668.02M | 689.05M | 675.29M | 531.91M | 541.32M | 560.44M | 336.68M | 302.15M | 294.07M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | -466.89M | -470.67M | -426.29M | -386.95M | -352.18M | -340.52M | -472.2M | -438.99M | -408.37M | -615.71M | -643.04M | -608.94M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -269K | 641K | 525K | -15K | 85K | -82K | 1.34M | -249K | -229K | -105K | -170K | -198K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |